Group 1 - The core focus of the collaboration is on the innovative development and application of high-performance silicone materials in the healthcare sector, aiming for a new chapter in upstream and downstream synergy within the industry chain [2] - This partnership aligns with the national "Healthy China 2030" strategy and the trend of upgrading the medical device industry, reflecting a significant practice in response to policy guidance and social demand [5][6] - The collaboration aims to break down barriers between material research and end-use applications, showcasing strategic mutual trust between the two companies and highlighting the immense potential of the Chinese healthcare market [10] Group 2 - At the recent China International Import Expo, the company launched the world's first special silicone rubber series for biomedicine, providing specialized solutions for various needs in the healthcare field [6] - The SILBIONE™ RTV 4140 CL is specifically designed for in vitro diagnostic (IVD) biochips, while the SILBIONE™ BLD 8010 high-performance silicone elastomer offers quick formation of a flexible, transparent protective film for wound care, promoting healing and skin repair [6]